A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Trial Locations (24)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10029

Mount Sinai Med Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

21287

Johns Hopkins Hosp, Baltimore

29169

Julio Arroyo, West Columbia

30308

Emory Univ, Atlanta

46202

Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

80262

Univ of Colorado Health Sciences Ctr, Denver

94025

Willow Clinic, Menlo Park

96816

Univ of Hawaii, Honolulu

275997215

Univ of North Carolina, Chapel Hill

331361013

Univ of Miami School of Medicine, Miami

452670405

Univ of Cincinnati, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

921036325

Univ of California / San Diego Treatment Ctr, San Diego

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

San Francisco Gen Hosp, San Francisco

943055107

San Mateo AIDS Program / Stanford Univ, Stanford

Stanford Univ Med Ctr, Stanford

951282699

Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000907 - A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients | Biotech Hunter | Biotech Hunter